CrushSCI.com
171.4平均天数
143.5中位天数
77最短天数
562最长天数
262025发文量

Paper Review Records

全部论文审稿周期

14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

98 天

Drug repurposing for TAK1 inhibition in inflammatory diseases and cancer: virtual screening identifies nilotinib and dabrafenib as potential candidates

作者
Jaber A. Alshehri; Turki Alfuhayr展开收起
作者单位
1. Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University展开收起
PDF源文件 DOI 网页
143 天

Computational exploration of phycobiliproteins-derived peptides: in-silico gastrointestinal digestion and multi-target molecular docking against Alzheimer’s disease-related enzymes

作者
Ibtissam Lijassi; Zineb Mansouri; Laila Rhazi; Imane Wahby展开收起
作者单位
1. Research Center of Plant and Microbial Biotechnologies, Biodiversity and Environment, Laboratory of Botany and Valorisation of Plant and Fungal Resources, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat展开收起
PDF源文件 DOI 网页
94 天

Computational identification of Allium sativum phytochemicals with predicted binding to the dopamine D2 receptor relevant to bipolar disorder

作者
Murat Kaan Pekgoz; Tunc Catal; Belkıs Atasever-Arslan展开收起
作者单位
1. Neuroscience Program, Health Sciences Institute, Uskudar University; 2. Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University; 3. Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Uskudar University展开收起
PDF源文件 DOI 网页
200 天

In silico investigation of novel isatin derivatives as potential multi-target anticancer agents targeting VEGFR-2, EGFR, and caspase-6

作者
Vipul Kumar; Vivek Kumar; Prabodh Chander Sharma; Deepak Sheokand; Ajit Kumar; Sahil Kumar展开收起
作者单位
1. Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), Delhi Pharmaceutical Sciences and Research University; 2. Toxicology and Computational Biology Group, Centre for Bioinformatics, Maharshi Dayanand University; 3. Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University展开收起
PDF源文件 DOI 网页
108 天

Identification of receptor-interacting protein kinase 3 inhibitor for atherosclerosis

作者
Angneh Ngoruh; Ananya Anurag Anand; Rik Ganguly; Shashi Kumar Yadav; Prosperwell Ingty; Sintu Kumar Samanta; Atanu Bhattacharjee展开收起
作者单位
1. Department of Biotechnology & Bioinformatics, North-Eastern Hill University; 2. Department of Applied Sciences, Indian Institute of Information Technology展开收起
PDF源文件 DOI 网页
144 天

Pharmacophore-based identification and molecular docking of CCR5 inhibitors: insights from dynamic simulations

作者
Angadi Sathish Kumar; Estari Mamidala展开收起
作者单位
1. Infectious Diseases Research Lab, Department of Zoology, Kakatiya University展开收起
PDF源文件 DOI 网页

FAQ

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION审稿要多久?

截至2026-11-19,CrushSCI 收录了 JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION 的 14 篇完整审稿记录。最快一篇从收稿到录用用了 77 天(Role of selective U-II receptor antagonists in modifying vascular function in intact and denuded aortic diabetic rats,2025-10-19 收稿,2026-01-04 录用),最慢一篇用了 562 天;平均 171.4 天,中位数 143.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。